BeOne Medicines (ONC) Change in Accured Expenses (2015 - 2026)

BeOne Medicines (ONC) has 12 years of Change in Accured Expenses data on file, last reported at -$16.8 million in Q1 2026.

• On a quarterly basis, Change in Accured Expenses fell 516.0% year-over-year to -$16.8 million in Q1 2026; TTM through Mar 2026 was $290.9 million, a 2970.25% increase from a year earlier, with the FY2025 full-year figure at $311.8 million, up 2201.11% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at -$16.8 million, down from $308.2 million in the prior quarter.
• Over the last five years, Change in Accured Expenses for ONC reached as high as $308.2 million in Q4 2025 and fell as low as -$78.8 million in Q1 2022.
• Historically, Change in Accured Expenses has averaged $29.8 million across 5 years, with a median of $3.2 million in 2022.
• On a YoY basis, Change in Accured Expenses climbed as much as 5479.83% in 2022 and fell as far as 25919.67% in 2022.
• Year by year, Change in Accured Expenses stood at $44.0 million in 2022, then jumped by 309.23% to $180.1 million in 2023, then sank by 108.17% to -$14.7 million in 2024, then jumped by 2195.25% to $308.2 million in 2025, then sank by 105.46% to -$16.8 million in 2026.
• Per Business Quant data, the three most recent Change in Accured Expenses figures were -$16.8 million in Q1 2026, $308.2 million in Q4 2025, and $3.5 million in Q3 2025.